by hleonhardt | Apr 19, 2016 | Uncategorized
Leonhardt Ventures, CerebraCell & BioLeonhardt File Provisional Patent Application For Electrical Stimulation Controlled Release of IGF-1 Key Tool in Regenerating Brains, Hearts, Eyes, Livers, Kidneys, Breasts, Lungs, Pancreas, Skin, Aortas, Heart Valves, Joints,...
by hleonhardt | Apr 19, 2016 | Uncategorized
Two Entities Seek to Collaborate to Grow Bioscience Startups into Thriving Businesses Los Angeles, California – LABioHub, the Los Angeles-based consortium dedicated to aiding the growth of biomedical enterprises in the region, announced this morning their...
by hleonhardt | Apr 2, 2016 | Uncategorized
Leonhardt Ventures & BioLeonhardt Technology Showcase During ACC Chicago April 2nd, 2016 – New Larger Venue Notice Los Angeles, CA, Salt Lake City, UT, Chicago, IL – March 31st, 2016 – Leonhardt Ventures and BioLeonhardt to Present Technology...
by hleonhardt | Feb 18, 2016 | Uncategorized
Santa Monica, CA and Salt Lake City, Utah , Feb. 16th, 2016 /PRBuzz- BioLeonhardt MyoStimwww.bioleonhardt.com funded by Leonhardt Ventures a developer, manufacturer and marketer of advanced organ regeneration products focused on the heart and limbs has announced the...
by hleonhardt | Jun 29, 2015 | Uncategorized
Leonhardt Ventures and Cal-X Stars Business Accelerator 1H 2016 Newsletter – 2015 Annual Report Summary Leonhardt Ventures founded 1982* 20+ direct U.S. patents for treating cardiovascular disease & dozens indirect 30 more patents in process or pending. ...
by hleonhardt | Jun 15, 2015 | Uncategorized
Santa Monica, CA – June 12th, 2015 – Today Leonhardt Ventures announced its progress in developing Cal-X The California Stock Exchange TM intended to be first social good impact stock exchange in the USA. “Treating people and community well with a strong sense of...
